Texas 2025 - 89th Regular

Texas House Bill HB350

Voted on by House
 
Out of Senate Committee
 
Voted on by Senate
 
Governor Action
 
Bill Becomes Law
 

Caption

Relating to the use of glucagon medication on certain public and private school campuses.

Impact

If enacted, HB 350 will result in important changes to the health protocols in schools across Texas. The bill empowers unlicensed diabetes care assistants to administer glucagon, thereby alleviating potential delays in treatment while also ensuring that glucagon is readily available for emergencies. The requirement for a diabetes management plan submitted by parents or guardians reinforces the communication between families and schools, promoting a collective effort to care for students with diabetes. Additionally, the bill emphasizes that schools are not mandated to incur costs related to the purchase of glucagon medication, which could influence school budgeting decisions.

Summary

House Bill 350 aims to regulate the use of glucagon medication on public and private school campuses in Texas. The bill defines glucagon medication as any medication used to treat hypoglycemia and sets forth guidelines for its maintenance and administration in school settings. Schools may adopt policies that allow designated school employees to administer glucagon to students who are suspected of experiencing hypoglycemia, provided that appropriate diabetes management and individualized health plans are in place. This initiative addresses the needs of diabetic students and aims to enhance their safety during school hours, thus ensuring a supportive educational environment.

Contention

Notable points of contention surrounding HB 350 may arise from concerns over the training and responsibility of non-healthcare professionals administering glucagon. Critics may argue that without adequate training and oversight, there could be risks associated with improper administration. Furthermore, there may be debates regarding the adequacy of resources states can provide to ensure that schools have the necessary supplies and staff for implementing the policies outlined in the bill. Balancing the need for immediate medical response with the implications for school resources and liability will likely be a key discussion point as the bill moves forward.

Texas Constitutional Statutes Affected

Health And Safety Code

  • Chapter 168. Care Of Students With Diabetes
    • Section: New Section

Occupations Code

  • Chapter 157. Authority Of Physician To Delegate Certain Medical Acts
    • Section: New Section

Companion Bills

No companion bills found.

Previously Filed As

TX HB2891

Relating to the use of glucagon medication on certain public and private school campuses.

Similar Bills

NJ A1882

Concerns administration of ready-to-use undesignated glucagon rescue therapy in public schools.

WV SB92

Glucagon for Schools Act

FL H0597

Diabetes Management in Schools

DC B25-0226

Access to Emergency Albuterol and Glucagon Amendment Act of 2023 (now known as "Access to Emergency Medications Amendment Act of 2023")

TX HB2891

Relating to the use of glucagon medication on certain public and private school campuses.

MA H556

Relative to undesignated glucagon rescue therapies in schools

MA H671

Relative to undesignated glucagon rescue therapies in schools

TX SB2535

Relating to the use of prescription glucagon medication on public and private school campuses.